
Ovid Therapeutics has announced the appointment of Karen Bernstein to the company’s Board of Directors. Dr Bernstein says: “I have …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions

